Department of Health and Human Services

Part 1. Overview Information
Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

Office of Research on Women’s Health (ORWH)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Library of Medicine (NLM)
Fogarty International Center (FIC)
National Center for Complementary and Alternative Medicine (NCCAM)
Division of Program Coordination, Planning and Strategic Initiatives, (DPCPSI)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Dietary Supplements (ODS)

Funding Opportunity Title

Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)

Activity Code

Administrative Supplement

Additional funds may be awarded as supplements to parent awards using the following Activity Code(s):
P01 Research Program Projects
P20 Exploratory Grants
P30 Center Core Grants
P50 Specialized Center
P51 Primate Research Center Grants
P60 Comprehensive Center
S06 Research-Related Programs
U10 Cooperative Clinical Research – Cooperative Agreements
U19 Research Program – Cooperative Agreements
U54 Specialized Center- Cooperative Agreements
U56 Exploratory Grants – Cooperative Agreements
UM1 Multi-Component Research Project Cooperative Agreements
DP1 NIH Director’s Pioneer Award (NDPA)
DP2 NIH Director’s New Innovator Awards
DP3 Type 1 Diabetes Targeted Research Award
DP4 NIH Director’s Pathfinder Award- Multi-Yr Funding
DP5/UP5 Early Independence Award/Cooperative Agreement
R01 Research Project Grant
R15 Academic Research Enhancement Award (AREA)
R37 Method to Extend Research in Time (MERIT) Award
U01 Research Project – Cooperative Agreements

Announcement Type

New

Related Notices

Funding Opportunity Announcement (FOA) Number

PA-13-018

Companion Funding Opportunity

None

Number of Applications

See Section III. 3. Additional Information on Eligibility.

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.313; 93.393;93.394;93.395;93;396;93.399;93.867; 93.172;93.866;93.273;93.846;93.286;93.865;93.279;93.173;93.121;93.847;93.113;93.859;93.242;93.307; 93.853;93.361;93879;93.989;93.350;93.213;93.839; 93.838;93.837;93.856;93.855

Funding Opportunity Purpose

The NIH announces the availability of administrative supplements to support research highlighting the impact of sex/gender differences (or similarities) in human health, including behavioral, clinical or preclinical studies. Included are studies relevant to the pathophysiology, clinical presentation, prevention, or treatment of disease. The proposed research should address the objectives of the NIH Strategic Plan for Women’s Health and Sex Differences  Research (http://orwh.od.nih.gov/research/strategicplan/index.asp).

Key Dates
Posted Date

November 13, 2012

Open Date (Earliest Submission Date)
Letter of Intent Due Date(s)

Not Applicable

Application Due Date(s)

January 11, 2013, by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s)

January 11, 2013, by 5 PM local time of applicant organization.

Scientific Merit Review

Not Applicable

Advisory Council Review

Not Applicable

Earliest Start Date

June 2013

Expiration Date

January 12, 2013

Due Dates for E.O. 12372

Not Applicable

Required Application Instructions

It is critical that applicants follow the instructions in the Application Guide (SF424 (R&R) Application Guide or PHS 398 Application Guide, as appropriate) except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

Table of Contents

Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

PURPOSE

The mission of the NIH is to seek fundamental knowledge about the nature and behavior of living systems, and to apply that knowledge to enhance health, lengthen life, and reduce burdens of illness and disability. The Office of Research on Women’s Health (ORWH) works in partnership with the NIH institutes, centers, and offices to ensure that women’s health and sex/gender differences research is part of the scientific framework.

This FY 2013 Administrative Supplement program is designed to support research that increases understanding of sex and gender differences in health and disease, as part of the implementation of the strategic plan entitled Moving Into The Future With New Dimensions and Strategies: A Vision for 2020 for Women’s Health Research, http://orwh.od.nih.gov/research/strategicplan/index.asp  

BACKGROUND

Women and men are characterized by both sex and gender, as highlighted in the Institute of Medicine (IOM) report, entitled Exploring the Biological Contributions to Human Health: Does Sex Matter? (2001). In this context, sex referred to being male or female according to reproductive organs and biologic functions assigned by chromosomal complement. Factors that contribute to biological sex differences include chromosomes, reproduction, and hormones. Gender referred to socially defined and derived expectations and roles rooted in biology and shaped by the environment and experience. Sex and gender are important considerations in many areas of research, including basic biological, psychological, social, and behavioral studies. Consideration of these variables is critical to the accurate interpretation and validation of research findings that affect the various aspects of women’s health and sex/gender differences research and to the development of personalized approaches to medicine.  Sex and gender variables may also determine how health and disease processes differ among women, or between women and men, and inform the development and testing of preventive and therapeutic interventions in both sexes.   

The 2010 NIH Strategic Plan for Women’s Health and Sex Differences Research, Moving into the Future with New Dimensions and Strategies, includes five research goals to advance women’s health and a number of specific objectives under each of the five goals to which the reader is referred for examples of general areas in which sex/gender differences research is encouraged. These include a broad range of research on sex/gender differences in basic science, incorporation of sex/gender differences in the design of new medical and communication technologies, medical devices and therapeutic drugs; global health research and in the development of approaches to personalized medicine.  The proposed research in the supplement needs to clearly demonstrate how the funding will address sex/gender differences.  However, the specific examples under the objectives are meant to be illustrative but not restrictive of the kinds of research that could be conducted to fulfill the goal of the administrative supplement. Please see the NIH Strategic Plan, http://orwh.od.nih.gov/research/strategicplan/index.asp

SCOPE OF SUPPORT

The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives as long as they are within the original scope of the project.  Any cost increases need to result from making modifications to the project in order to take advantage of opportunities that would increase the value of the project consistent with its originally approved objectives and purposes.

The research proposed under the administrative supplement program must be within the original scope of the parent grant.  Applicants should propose research that, if successful, would contribute to a greater understanding of the implications of sex/gender differences (or similarities) in human health or disease outcomes.   Applicants must address how the proposed research supports the goals and objectives of the NIH Strategic Plan for Women’s Health and Sex Differences Research by including a statement at the beginning of the Research Strategy section of the application. 

For example, applicants may use the following approaches to address sex/gender comparisons:

Applicants proposing the addition of subjects to Phase III clinical trials will be considered non-responsive.

IC Specific Considerations

Applicants are strongly encouraged to discuss their proposed supplement project with the IC Program Officer of the parent grant prior to submission of a supplement application in order to ensure that the supplement content area fits with the scientific priorities of the IC and is within the scope of the parent grant; and to ensure that the parent grant mechanism is one the IC will support for a supplement.

Section II. Award Information
Funding Instrument

The funding instrument will be the same as the parent award. 

Application Types Allowed

Non-competing Administrative Supplements

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. ORWH and the participating components intend to commit up to $3.5 million for FY 2013 funding.

Award Budget

Application budgets are limited to no more than the amount of the current parent award, and must reflect actual needs of the proposed project.

Budget requests may be for no more than $100,000 in total costs.

The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the project, or the cost increases are for unanticipated expenses within the original scope of the project. Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and purposes.

Award Project Period

The project and budget periods must be within the currently approved project period for the existing parent award. Only active awards with at least 18 months remaining will be considered. Awards in no-cost extension periods are not allowed to submit an application in response to this FOA.   

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

All organizations administering an eligible parent award may apply for a supplement under this announcement.

Higher Education Institutions

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

Nonprofits Other Than Institutions of Higher Education

For-Profit Organizations

Governments

Other

This announcement is for supplements to existing projects. To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment. The proposed supplement must be to provide for an increase in costs due to unforeseen circumstances. All additional costs must be within the scope of the peer reviewed and approved project.

IMPORTANT: The research proposed by the NIH grantee in the supplement application must be within the original scope of the NIH-supported grant project. Applications that propose to add human subjects in order to conduct exploratory analyses, facilitate sex/gender differences analysis /or to analyze existing data sets that are adequately powered are considered to be within the scope of the parent grant

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Foreign institutions or domestic institutions with foreign components must have clearance for shipping of biological samples across international lines prior to the administrative supplement award.

Required Registrations

Applicant organizations must complete the following registrations as described in the Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.

All Program Directors/Principal Investigators (PD(s)/PI(s)) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.

All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least 6 weeks prior to the application due date.

Eligible Individuals (Program Director/Principal Investigator)

Individual(s) must hold an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award. Individuals are invited to work with their organizations to develop applications for support.

For supplements to parent awards that include multiple PDs/PIs, the supplement may be requested by any or all of the PDs/PIs (in accordance with the existing leadership plan) and submitted by the awardee institution of the parent award. Do not use this administrative supplement application to add, delete, or change the PDs/PIs listed on the parent award. Visit the Multiple Program Director/Principal Investigator Policy in the SF424 (R&R) Application Guide for more information.

2. Cost Sharing

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

3. Additional Information on Eligibility

Number of Applications

Applicant organizations may submit more than one application, provided that each is sufficiently distinct from any other administrative supplement currently under consideration by the awarding NIH Institute or Center.

Since applications in response to this announcement will only receive administrative review by the awarding Institute or Center, and will not receive a peer review, the NIH policy on resubmissions will not apply. However, applications not accepted by the Institute or Center for review, or not funded by the Institute or Center, should not be submitted again without either responding to any written concerns or contacting the awarding Institute or Center for instructions first.  

Section IV. Application and Submission Information

1. Requesting an Application Package

Applicants are required to prepare applications according to the current application forms in accordance with the Application Guide.

For electronic submissions, applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this announcement, or use the eRA Commons streamlined submission process.

2. Content and Form of Application Submission

All forms should be completed for the supplemental activities only and should not reflect funding or activities for the previously awarded parent award.

It is critical that applicants follow the instructions in the Application Guide (SF424 (R&R) Application Guide or PHS 398 Application Guide, as appropriate) except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.

Page Limitations

All page limitations described in the Application Guide and the Table of Page Limits must be followed, with the following exceptions or additional requirements:

Application Submission

The process for submitting an application varies depending on whether the activity code of the parent award requires electronic submission (as of the submission date of the supplement application). Visit the list of Activity Codes Processed Electronically by eRA to determine if the activity code of the parent award has transitioned to electronic submission.

Instructions for Submissions using Grants.gov/Apply for electronic-based submissions

For grants with activity codes that have transitioned to electronic submission using the SF424 (R&R) application forms, administrative supplement requests may be submitted electronically as a Revision application type on the R&R Cover Component. Prepare applications using the SF424 (R&R) application forms associated with this announcement. Please note that some components marked optional in the application package are required for submission of applications for this announcement. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate required and optional components.

Special Instructions for Streamlined Submissions using the eRA Commons for electronic-based submissions

NIH now offers a streamlined system through the eRA Commons for submitting administrative supplements. Login to the eRA Commons, identify the parent award, and prepare an administrative supplement request. A User’s Guide for submitting through this system is available.

Include the Research Strategy and any other required documentation (described below) as a PDF file using the “Add Other Attachments” function.  Budget information should be entered for the grantee institution in the fields provided. There is no template or form available for subaward information; instead, all subaward information should be included as a separate attachment showing the funds requested (by budget period) using the same categories provided for the grantee institution. Also include a budget justification for the subawardee institution in the same file.

Instructions for Submissions using the PHS 398 Application Forms (for paper-based submissions)

Applications must be prepared using the PHS 398 research grant application forms and instructions for preparing a research grant application. The grantee institution, on behalf of the PD/PI of the parent award, must submit the request for supplemental funds directly to the awarding component that supports the parent award. Submit a signed, typewritten original of the application, including the checklist, and two signed photocopies in one package to the Agency Contact listed in the Scientific/Program Contact(s) section for the IC that funded the parent award.

On the face page of the application form, note that your application is in response to a specific program announcement, and enter the title and number of this announcement.

PHS 398 Research Plan Component (Research Plan)

All instructions in the Application Guide must be followed for all Research Plan sections applicable to the proposed supplement activities. At a minimum, the Research Strategy section should be completed and must include a summary or abstract of the funded parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities. Applicants should include a statement of relevance of the proposed research to the goals and objectives of the NIH Strategic Plan for Women’s Health ((http://orwh.od.nih.gov/research/strategicplan/index.asp as the first sentence of the research strategy.

Project/Performance Site Locations (Project/Performance Sites)

Include the primary site where the proposed supplement activities will be performed. If a portion of the proposed supplement activities will be performed at any other site(s), identify the locations in the fields provided.

Senior/Key Personnel Form

List the PD/PI as the first person (regardless of their role on the supplement activities). List any other Senior/Key Personnel who are being added through this supplement, or for whom additional funds are being requested through this supplement; include a biographical sketch for each. Follow all instructions in the Application Guide. The PD/PI must be the same as the PD/PI on the parent award.  For Multiple PD/PI parent awards, the Contact PD/PI must be the PD/PI listed on the supplement request, and the supplement cannot change the Multiple PD/PI team. 

R&R Detailed Budget Form (for use with electronic submissions)

All budgets should be submitted using the R&R Detailed Budget form, regardless of the form used for the parent award, and should only include funds requested for the additional supplement activities.

Budget for the Entire Proposed Period of Support (for use with paper-based submissions)

A proposed budget should be submitted using the PHS 398 budget forms, in accordance with the PHS 398 Application Guide, and should only include funds requested for the additional supplement activities.

Other Project Information Component (for applications submitted electronically); Appendix (for applications submitted on paper)

All instructions in the Application Guide must be followed, with the following additional instructions:

IACUC Documentation and IRB Documentation (Uploaded via the Other Attachments Section for electronic submissions)

The filename provided for each “Other Attachment” will be the name used for the bookmark in the electronic application in eRA Commons.

Foreign Institutions

Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the Application Guide.

3. Submission Dates and Times

Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit applications before the deadline to ensure they have time to make any application corrections that might be necessary for successful submission.

Organizations must submit applications as described above. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration.

Applicants are responsible for viewing their application before the deadline in the eRA Commons to ensure accurate and successful submission.

For electronic application submission, information on the submission process and a definition of on-time submission are provided in the SF424(R&R) Application Guide.

For paper-based application submission, information on the process of receipt and determining if your application is considered “on-time” is described in detail in the PHS 398 Application Guide.

4. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

5. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.  

6. Other Submission Requirements and Information

Applications must be submitted using the instructions specified above

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.

Important reminders:
For applications submitted electronically on the SF424 (R&R) Application forms, all PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF 424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.

The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management (SAM). Additional information may be found in the Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness by the awarding Institute or Center. Applications that are incomplete and/or nonresponsive will not be reviewed.

Post Submission Materials

Not Applicable.

Section V. Application Review Information

1. Criteria

Administrative Supplements do not receive peer review. Instead, the administrative criteria described below will be considered in the administrative evaluation process.

This process involves an initial selection by each participating NIH institute and center (IC), and a subsequent selection of supplements to be funded from among the highest ranked supplements submitted by all ICs participating in this announcement.  An integration panel, with ORWH coordination, will make the final selections.  The following general criteria will be used:

Budget and Period of Support

NIH Staff will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

Overall Impact

NIH staff will consider the ability of the proposed supplement activities to increase or preserve the parent award’s overall impact within the original scope of award:

In addition, each of the following criteria will be evaluated as applicable for the proposed supplement.

Protections for Human Subjects:

For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, NIH staff will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, NIH staff will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Human Subjects Protection and Inclusion Guidelines.

Inclusion of Women, Minorities, and Children

When the proposed project involves clinical research, NIH staff will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.

Vertebrate Animals

NIH Staff will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.

Biohazards

NIH Staff will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.

2. Review and Selection Process

Administrative supplement requests will undergo an administrative evaluation by NIH staff, but not a full peer review. Applications submitted for this funding opportunity will be assigned to the awarding component for the parent award and will be administratively evaluated using the criteria shown above.

After IC review and ranking of supplement applications, ORWH will develop a funding plan with consideration of the following factors:

3. Anticipated Announcement and Award Dates

Not Applicable

Section VI. Award Administration Information

1. Award Notices

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. This may be as an NoA for the supplemental activities only; alternatively, it may be as either a revision to the current year NoA or included as part of a future year NoA. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee’s business official.

Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.    

Any application awarded in response to this FOA will be subject to the DUNS, SAM Registration, and Transparency Act requirements as noted on the Award Conditions and Information for NIH Grants website.

2. Administrative and National Policy Requirements

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.

Cooperative Agreement Terms and Conditions of Award

Any supplements to Cooperative Agreements will be subject to the same Cooperative Agreement terms and conditions as the parent award.

3. Reporting

Reporting requirements will be specified in the terms and conditions of award as applicable to the supplemental activities. In most non-competing continuation applications, the progress report and budget for the supplement must be included with, but clearly delineated from, the progress report and budget for the parent award. The progress report must include information about the activities supported by the supplement even if support for future years is not requested. Continuation of support for the supplement activities in the remaining years of the competitive segment of the grant will depend upon satisfactory review by the NIH awarding component of progress for both the parent award and the supplement project, the research proposed for the next budget period, and the appropriateness of the proposed budget for the proposed effort. This information is submitted with the  Non-Competing Grant Progress Report, PHS 2590 or RPPR, and financial statements as required in the NIH Grants Policy Statement.

The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

Grants.gov Customer Support (Questions regarding Grants.gov registration and submission, downloading or navigating forms)
Contact Center Phone: 800-518-4726
Email: support@grants.gov

GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
Telephone 301-435-0714
TTY 301-451-5936
Email: GrantsInfo@nih.gov

eRA Commons Help Desk (Questions regarding eRA Commons registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: commons@od.nih.gov

Scientific/Research Contact(s)

Participating Organization and Website

Contact Information

Office of Research on Women’s Health (ORWH) http://orwh.od.nih.gov/

Lisa Begg, Dr.P.H., R.N.
Director of Research Programs
Office of Research on Women’s Health/OD/NIH
6707 Democracy Boulevard, Suite 400
Bethesda, MD 20892-5484 (For overnight mail, please use Bethesda, MD 20817) 
Phone:  301-496-7853 (direct); 301-402-1770 (ORWH phone number)
E-mail:  beggl@od.nih.gov

Mary C. Blehar, Ph.D.
Senior Research Advisor
Office of Research on Women’s Health/OD/NIH
6707 Democracy Boulevard, Suite 400
Bethesda, MD 20892-5484
Phone:  301-496-9006 (direct); 301-402-1770 (ORWH phone number)
E-mail:  bleharmc@od.nih.gov

National Cancer Institute, (NCI) www.cancer.gov

Karen Parker, Ph.D.
Women’s Health Officer
Office of Science Planning and Assessment/NCI
6116 Executive Boulevard, Suite 205
Rockville, MD 20892
Phone:  301-451-9462
E-mail:  klparker@mail.nih.gov

National Eye Institute (NEI)  www.nei.nih.gov

Lisa A. Neuhold, Ph.D.
Division of Extramural Research/NEI
5635 Fishers Lane, Suite 1300
Bethesda, MD 20892-9300
Phone: 301-451-2020
FAX: 301-402-0528
E-mail: lneuhold@mail.nih.gov

National Heart Lung and Blood Institute (NHLBI)

www.nhlbi.nih.gov

Shari Eason Ludlam, MPH
Two Rockledge Center, Room 9188/NHLBI
6701 Rockledge Drive
Bethesda, MD 20892
Phone: 301-435-6667  
E-mail: ludlams@nhlbi.nih.gov

National Human Genome Research Institute (NHGRI) www.genome.gov

Jean E. McEwen, J.D., Ph.D.
Program Director/NHGRI
5635 Fishers Lane, Suite 4076
Bethesda, MD 20892-9306
Phone:  301-496-7531
E-mail: jean.mcewen@nih.hhs.gov

National Institute on Aging (NIA) www.nia.nih.gov

Judy Hannah, Ph.D.
Geriatrics and Clinical Gerontology Program/NIA
Gateway Building, 3C307
7201 Wisconsin Avenue
Bethesda, MD  20892-9205
Phone: 301-435-0044
E-mail: hannahj@nia.nih.gov

National Institute on Alcohol Abuse and Alcoholism (NIAAA) www.niaaa.nih.gov

Svetlana Radaeva, Ph.D.
Division of Metabolism and Health Effects/NIAAA
5635 Fishers Lane
Rockville, MD 20852
Phone: 301-443-1189
E-mail: sradaeva@mail.nih.gov

National Institute of Allergy and Infectious Diseases (NIAID) www.niaid.nih.gov

Tamara Lewis-Johnson, M.B.A., M.P.H.
Office of Extramural Research Policy and Operations, NIAID
Room 2145, 6700-B Rockledge Drive
Bethesda, MD 20892
Phone: 301-451-7942
E-mail: lewisjohnson@niaid.nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) www.niams.nih.gov

Bernadette Tyree, Ph.D.
Director, Cartilage and Connective Tissue Program/NIAMS
6701 Democracy Blvd., Suite 800
Bethesda, MD 20892-4872
Phone: 301-594-5055
FAX: 301-480-1284
E-mail: tyreeb@mail.nih.gov

National Institute of Biomedical Imaging and Bioengineering (NIBIB) www.nibib.nih.gov

Rosemarie Hunziker, Ph.D.
Program Director, Tissue Engineering and Regenerative Medicine/NIBIB
6707 Democracy Boulevard, Room 235 
Bethesda, MD  20892-5477
Phone:  301-451-1609
E-mail:  hunzikerr@mail.nih.gov

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) www.nichd.nih.gov

Estella C Parrott, M.D., M.P.H.
Medical Officer, Contraceptive and Reproductive Health Branch, NICHD
6100 Executive Blvd, Executive Bldg, 8B-13
Bethesda, MD  20892-7510
Phone:  301-435-6971
E-mail: parrotte@mail.nih.gov

National Institute on Deafness and Other Communication Disorders (NIDCD) www.nidcd.nih.gov

Lana Shekim, Ph.D.
Division of Scientific Programs/NIDCD
Executive Plaza South, 400-C
6120 Executive Boulevard
Rockville, MD 20852
Phone : 301-496-5061
E-mail: shekiml@nidcd.nih.gov

National Institute of Dental and Craniofacial Research (NICDR) www.nidcr.nih.gov

Jane Atkinson, D.D.S.
Director, Center for Clinical Research/NIDCR
6701 Democracy Blvd, Room 634
Bethesda, MD 20892-4878
Phone: 301-435-7908
FAX: 301-480-8322
E-mail: jatkinso@mail.nih.gov

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) www2.niddk.nih.gov/

Chris Mullins, Ph.D.
Director of Basic Cell Biology Programs
Division of Kidney, Urologic and hematologic Diseases/NIDDK
6707 Democracy Blvd, Room 637
Bethesda, Maryland 20892-5458 
Phone: 301-451-5458
FAX: 301-480-3510
E-mail: mullinsc@extra.niddk.nih.gov

National Institute on Drug Abuse (NIDA) www.nida.nih.gov

Cora Lee Wetherington, Ph.D.
Women & Sex/Gender Differences Research Coordinator/NIDA
6001 Executive Boulevard, Rm 4282
Bethesda, MD 20892-9555 (For deliveries:  Rockville, MD 20852)
Phone: 301-435-1319
E-mail: cwetheri@nida.nih.gov

National Institute of Environmental Health Sciences (NIEHS) www.niehs.nih.gov

Caroline Dilworth, Ph.D.
Program Administrator, NIEHS
530 Davis Drive, Bldg: Keystone Bldg., Rm. 3066
Durham, NC 27713
Phone: 919-541-7727
Email: dilworthch@niehs.nih.gov

National Institute of General Medical Sciences (NIGMS) www.nigms.nih.gov 

Paula Flicker, Ph.D.
45 Center Drive, 2AS-13H, NIGMS
Bethesda, MD, 20892-6200
Phone: 301-594-0828
FAX: 301-480-2004
E-mail: flickerp@nigms.nih.gov

National Institute of Mental Health (NIMH) www.mentalhealth.gov

Kathleen O’Leary, M.S.W.
Acting Chief, Women's Program
Office for Research on Disparities and Global Mental Health/NIMH
6001 Executive Boulevard, Room 8125
Rockville MD 20892-9659
Phone: 301-443-3945
FAX:  301-443-8552
E-mail: Olearyk@mail.nih.gov

National Center on Minority Health and Health Disparities (NCMHD) http://www.ncmhd.nih.gov

Jennifer Alvidrez, Ph.D.
Program Official
Division of Scientific Programs, NIMHD
Suite 800, 6707 Democracy Blvd.
Bethesda, MD 20892-5465
Phone: 301-594-9567
Fax: 301-480-4049
E-mail: Jennifer.alvidrez@nih.gov

National Institute of Neurological Disorders and Stroke (NINDS) www.ninds.nih.gov

Vicky Holets Whittemore, PhD
NINDS/NIH
Program Director - Epilepsy
Channels, Synapses and Circuits
6001 Executive Blvd, Room 2107
Rockville, MD  20852
Phone:  301-496-1917
FAX:  301-402-1501
Email:  whittemorevr@mail.nih.gov

National Institute of Nursing Research (NINR),

http://www.ninr.nih.gov/

Xenia T. Tigno, Ph.D, M.S.
Program Officer
OEP, National Institute of Nursing Research, NIH
6701 Democracy Blvd, Suite 710
Bethesda MD 20882
Telephone: 301-594-2775
e-mail: tignoxt@mail.nih.gov

National Library of Medicine (NLM) www.nlm.nih.gov

Hua-Chuan Sim, Ph.D.
NLM Extramural Programs/NLM
Rockledge One, Suite 301
6705 Rockledge Drive
Bethesda, MD 20892-7968
Phone: 301-594-4882
E-mail: simh@mail.nih.gov

Fogarty International Center (FIC) www.fic.nih.gov

Jeanne McDermott, CNM, MPH, Ph.D.
Program Director
Division of International Training and Research/FIC
Building 31, Room B2C39
31 Center Drive
Bethesda, MD 20892-2220
Phone: 301-496-1492
FAX: 301-402-0779
E-mail: Jeanne.mcdermott@nih.gov

National Center for Complementary and Alternative Medicine (NCCAM) www.nccam.nih.gov

D. Lee Alekel, Ph.D.
Program Director, Women’s Health
Division of Extramural Research/NCCAM
6707 Democracy Boulevard, Suite 401
Bethesda, MD 20892 Phone: 301-443-8374
FAX: 301-480-1587 
E-mail : lee.alekel@nih.gov

Office of Behavioral and Social Sciences Research (OBSSR) obssr.od.nih.gov

Lisa Begg, Dr.P.H., R.N. (accepting emails and calls for OBSSR)
Director of Research Programs
Office of Research on Women’s Health/OD/NIH
6707 Democracy Boulevard, Suite 400
Bethesda, MD 20892-5484
Phone:  301-496-7853 (direct) ;  301-402-1770 (ORWH phone number)
E-mail:  beggl@od.nih.gov

Office of Dietary Supplements (ODS) ods.od.nih.gov

Cindy D. Davis, Ph.D.
Director, Grants and Extramural Activities
Office of Dietary Supplements/OD/NIH
6100 Executive Blvd., Room 3B01
Bethesda, Maryland 20892-7517
Phone: 301-496-0168
FAX: 301-480-1845
Email: davisci@mail.nih.gov

Peer Review Contact(s)

Not Applicable

Financial/Grants Management Contact(s)

Participating Organization and Website

Contact Information

Office of Research on Women’s Health (ORWH), http://orwh.od.nih.gov/

Lisa Begg, Dr.P.H., R.N,
Director of Research Programs
Office of Research on Women’s Health/OD/NIH
6707 Democracy Boulevard, Suite 400
Bethesda, MD 20892-5484
Phone:  301-496-7853 (direct); 301-402-1770 (ORWH phone number)
E-mail:  beggl@od.nih.gov

National Cancer Institute (NCI) www.cancer.gov

Crystal Wolfrey, Deputy Director
Office of Grants Administration/NCI
6120 Executive Boulevard
Executive Plaza South, Suite 243
Bethesda, MD 20892-7150 (For U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Phone: 301-496-86340
FAX: 301-496-8601
E-mail: wolfreyc@mail.nih.gov

National Eye Institute (NEI)  www.nei.nih.gov

Mr. William W. Darby
Division of Extramural Research/NEI
5635 Fishers Lane; Suite 1300
Bethesda, MD 20892-9300
Phone: 301-451-2020
FAX: 301-496-9997
E-mail: wwd@nei.nih.gov

National Heart Lung and Blood Institute (NHLBI) www.nhlbi.nih.gov

Kimberly O. Stanton
Grants Management Specialist
Office of Grants Management/NHLBI
Rockledge II Center
6701 Rockledge Drive, Suite 7167
Bethesda, MD 20892 (express zip 20817)
Phone:  301-435-0159 (Direct)
FAX:  301-451-5462
E-mail:  stantonk@mail.nih.gov

National Human Genome Research Institute (NHGRI) www.genome.gov

Cheryl Chick
Grants Administration Branch/NHGRI
Suite 4076
5635 Fishers Lane
Bethesda, MD 20892-9306
Phone: 301-435-7858
FAX: 301-402-1951
E-mail: ChickC@mail.nih.gov

National Institute on Aging (NIA) www.nia.nih.gov

Richard E. Proper
Grants Management Specialist/NIA
Gateway Building, Room 2N212
7201 Wisconsin Avenue
Bethesda, MD, 20892-9205
Phone: 301-402-7735
FAX : 301-402-3672
E-mail: properr@nia.nih.gov

National Institute on Alcohol Abuse and Alcoholism (NIAAA) www.niaa.nih.gov

Judy Fox
Chief, Grants Management Branch/NIAAA
5635 Fishers Lane, Room 3023
Bethesda, MD 20892-9304
Phone: 301-443-4704
FAX: 301-443-3891
E-mail: jfox@mail.nih.gov

National Institute of Allergy and Infectious Diseases (NIAID) www.niaid.nih.gov

Lesia A. Norwood
Deputy Chief, Grants Management Program/NIAID
6700B Rockledge Drive, Room 2116
Bethesda, MD  20892-7614
Phone: 301-402-7146
eFAX: 301-493-0597
E-mail: ln5t@nih.gov

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) www.niams.nih.gov

Andrew Jones
Deputy Grants Management Officer/NIAMS
6701 Democracy Boulevard, Suite 834
Bethesda, MD 20892-4872
Phone: 301-435-0610
FAX: 301-480-5450
E-mail:  jonesan@mail.nih.gov

National Institute of Biomedical Imaging and Bioengineering (NIBIB) www.nibib.nih.gov

Nancy Curling
Chief, Grants Management Office
Two Democracy Plaza
6707 Democracy Boulevard, Suite 900
Bethesda, MD, 20892-5469
Phone: 301-451-4782
FAX: 301-480-4974
E-mail:curlingn@mail.nih.gov

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) www.nichd.nih.gov

Bryan S. Clark, MBA
Chief, Grants Management Officer/NICHD
6100 Executive Boulevard, Room 8A01A
Rockville, Maryland 20852
Phone: 301-435-6975
E-FAX: 301-451-5510
E-mail: clarkb1@mail.nih.gov

National Institute on Deafness and Other Communication Disorders (NIDCD) www.nidcd.nih.gov

Christopher Myers
Division of Extramural Activities/NIDCD
6120 Executive Boulevard, EPS 400C
Bethesda, MD 20892-7180
Phone: 301-402-0909
FAX: 301-402-1758
E-mail: Myersc@mail.nih.gov

National Institute of Dental and Craniofacial Research (NICDR) www.nidcr.nih.gov

Mary Greenwood
Chief, Grants Management Branch/NIDCR
6701 Democracy Blvd, Room 658
Bethesda, MD 20892-4878
Phone: 301-594-4808
FAX: 301-480-3562
E-mail: daleym@mail.nih.gov

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH), www2.niddk.nih.gov

Diana Ly
Grants Management Branch/NIDDK
2 Democracy Plaza
6707 Democracy Boulevard, Room #723
Bethesda, MD 20892
Phone: 301-594-9249
FAX: 301-594-9523
E-mail:  dianaly@mail.nih.gov

National Institute on Drug Abuse (NIDA) www.nida.nih.gov

Yinka Abu
Grants Management Branch/NIDA
6001 Executive Blvd,
Rockville, MD 20852
Phone number: 301-595-0572
E-mail: abuy@nida.nih.gov

National Institute of Environmental Health Sciences (NIEHS) www.niehs.nih.gov

Molly Puente, PhD
Grants Management Branch/NIEHS
530 Davis Drive
Keystone Building, Room 3063, MD  K3-11
Research Triangle Park, NC 27709-2233
Phone:  919-541-1373
E-mail: puentem@mail.nih.gov

National Institute of General Medical Sciences (NIGMS) www.nigms.nih.gov

Lisa Moeller
45 Center Drive, Room 2AN-50C
Bethesda, MD, 20892-6200
Phone: 301-594-3914
FAX: 301-451-5601
E-mail: moellerl@mail.nih.gov

National Institute of Mental Health (NIH/NIMH) www.mentalhealth.gov

Tamara Kees
Neuroscience Center, Rm. 6124 MSC 9605
Mail: 6001 Executive Blvd., Room 8125, MSC 9659
Bethesda MD 20892-9605
301.443.8811
(for FedEx, UPS & other couriers:  Rockville MD 20892)

National Institute on Minority Health and Health Disparities (NCMHD) http://www.ncmhd.nih.gov

Priscilla Grant, J.D., C.R.A.
Chief Grants Management Officer
6707 Democracy Boulevard, Suite 800
Bethesda, Maryland 20892-5465
Phone: 301-594-8412
Fax:  301-480-4049
E-mail:  pg38h@nih.gov

National Institute of Neurological Disorders and Stroke (NINDS) www.ninds.nih.gov

Tijuanna Decoster
6001 Executive Boulevard/NINDS
Bethesda, MD 20892-5484
Phone: 301-496 9231
FAX: 301-402 0219
E-mail:  decostert@ninds.nih.gov

National Institute of Nursing Research (NINR) www.ninr.nih.gov

Randi Freundlich
Office of Grants and Contract Management/NINR
One Democracy Plaza
6701 Democracy Blvd, Room 710
Bethesda, MD 20892-4870
Phone: 301-594-5974
E-mail: freundlichr@mail.nih.gov

National Library of Medicine (NLM) www.nlm.nih.gov

Amy Keener
Grants Management Specialist
Extramural Programs/NLM
Rockledge 1, Suite 301
6705 Rockledge Drive
Bethesda, MD 20892-7968
Phone: 301-496-4221
E-mail: akeener@mail.nih.gov

Fogarty International Center (FIC) www.fic.nih.gov

Bruce Butrum
Chief Grants Management Officer/FIC
Building 31, Room B2C29
31 Center Drive
Bethesda, MD  20892-2220
Phone: 301-496-1670
FAX: 301-594-1211
E-mail:  butrumb@mail.nih.gov

National Center for Complementary and Alternative Medicine (NCCAM) www.nccam.nih.gov

George Tucker, MBA
Grants Management Office/NCCAM
6707 Democracy Boulevard, Suite 401
Bethesda, MD  20892-5475
Phone: 301-594-8853
FAX: 301-480-2419
E-mail: gt35v@nih.gov

Office of Behavioral and Social Sciences Research (OBSSR) obssr.od.nih.gov

Lisa Begg, Dr.P.H., R.N. (accepting calls for OBSSR)
Director of Research Programs
Office of Research on Women’s Health/OD/NIH
6707 Democracy Boulevard, Suite 400
Bethesda, MD 20892-5484 (For overnight mail, please use Bethesda, MD. 20817) 
Phone:  301-496-7853 (direct) ;  301-402-1770 (ORWH phone number)
E-mail:  beggl@od.nih.gov

Office of Dietary Supplements (ODS) ods.od.nih.gov

Cindy D. Davis, Ph.D., Director, Grants and Extramural Activities,/ODS/OD
6100 Executive Blvd., Room 3B01
Bethesda, Maryland 20892-7517
Phone: 301-496-0168
FAX: 301-480-1845
Email: davisci@mail.nih.gov

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Authority and Regulations

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.